C8957 HCPCS Level II code: Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump
C8957 is the HCPCS code for “Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
C8957Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump
Short description: Prolonged iv inf, req pump
HCPCS · United States
Medicare details
The indicators CMS publishes with C8957 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Value not established
- Type of service
- Medical care
- BETOS category
- Minor procedures - other (Non-Medicare fee schedule)
- Coverage statute
- 1833(t)
- Added
- Jan 1, 2006
Where C8957 sits
- 1C codesOutpatient prospective payment system
- 2Active code C8957Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code C8957 mean?
C8957 is the HCPCS code for “Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover C8957?
CMS lists C8957’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Value not established”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside C8957
All C codesC8932Magnetic resonance angiography without contrast, spinal canal and contentsC8933Magnetic resonance angiography without contrast followed by with contrast, spinal canal and contentsC8934Magnetic resonance angiography with contrast, upper extremityC8935Magnetic resonance angiography without contrast, upper extremityC8936Magnetic resonance angiography without contrast followed by with contrast, upper extremityC8937Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician…C9014Injection, cerliponase alfa, 1 mgC9015Injection, c-1 esterase inhibitor (human), haegarda, 10 unitsC9016Injection, triptorelin extended release, 3.75 mgC9021Injection, obinutuzumab, 10 mgC9022Injection, elosulfase alfa, 1mgC9023Injection, testosterone undecanoate, 1 mg